ID16283A - Senyawa yang berguna dibidang farmasi - Google Patents

Senyawa yang berguna dibidang farmasi

Info

Publication number
ID16283A
ID16283A IDP970892A ID970892A ID16283A ID 16283 A ID16283 A ID 16283A ID P970892 A IDP970892 A ID P970892A ID 970892 A ID970892 A ID 970892A ID 16283 A ID16283 A ID 16283A
Authority
ID
Indonesia
Prior art keywords
pharmaceutical
comfort used
comfort
Prior art date
Application number
IDP970892A
Other languages
English (en)
Indonesian (id)
Inventor
John Bantick
Peter Cage
Mark Furger
Matthew Perry
Roger Bonnert
David Donald
Simon Hirst
Eifion Phillips
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9605803.7A external-priority patent/GB9605803D0/en
Priority claimed from GBGB9610474.0A external-priority patent/GB9610474D0/en
Priority claimed from GBGB9610894.9A external-priority patent/GB9610894D0/en
Priority claimed from GBGB9700862.7A external-priority patent/GB9700862D0/en
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of ID16283A publication Critical patent/ID16283A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDP970892A 1996-03-20 1997-03-19 Senyawa yang berguna dibidang farmasi ID16283A (id)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9605803.7A GB9605803D0 (en) 1996-03-20 1996-03-20 Pharmaceutically-active compound
GBGB9610474.0A GB9610474D0 (en) 1996-05-18 1996-05-18 Pharmaceutically active compounds
GBGB9610894.9A GB9610894D0 (en) 1996-05-24 1996-05-24 Pharmaceutically useful compounds
GBGB9700862.7A GB9700862D0 (en) 1997-01-16 1997-01-16 Pharmaceutically useful compounds

Publications (1)

Publication Number Publication Date
ID16283A true ID16283A (id) 1997-09-18

Family

ID=27451427

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP970892A ID16283A (id) 1996-03-20 1997-03-19 Senyawa yang berguna dibidang farmasi

Country Status (19)

Country Link
EP (1) EP0888347A1 (cs)
JP (1) JP2000506884A (cs)
KR (1) KR20000064716A (cs)
CN (1) CN1218472A (cs)
AR (1) AR006520A1 (cs)
AU (1) AU712141B2 (cs)
BR (1) BR9708103A (cs)
CA (1) CA2247814A1 (cs)
CZ (1) CZ297798A3 (cs)
EE (1) EE9800298A (cs)
ID (1) ID16283A (cs)
IL (1) IL126271A0 (cs)
IS (1) IS4848A (cs)
NO (1) NO984290L (cs)
NZ (1) NZ331614A (cs)
PL (1) PL328921A1 (cs)
SK (1) SK118798A3 (cs)
TR (1) TR199801861T2 (cs)
WO (1) WO1997034893A1 (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10110749A1 (de) * 2001-03-07 2002-09-12 Bayer Ag Substituierte Aminodicarbonsäurederivate
JP2003002863A (ja) * 2001-06-25 2003-01-08 Nippon Soda Co Ltd 安息香酸類の製造方法および新規化合物
US6642249B2 (en) 2001-07-04 2003-11-04 Active Biotech Ab Immunomodulating compounds
SE0102404D0 (sv) * 2001-07-04 2001-07-04 Active Biotech Ab Novel immunomodulating compounds
DE10229762A1 (de) * 2002-07-03 2004-01-22 Aventis Pharma Deutschland Gmbh Pyrazoloisoquinolinenderivaten zur Inhibierung von NFkappaB-induzierende Kinase
CA2506524A1 (en) * 2002-11-22 2004-06-10 Active Biotech Ab Pyrazoloquinolines with immunomodulating activity
DE60326639D1 (de) 2002-12-16 2009-04-23 Active Biotech Ab Tetrazyklische immunmodulierende verbindungen
NZ541973A (en) 2003-03-14 2009-06-26 Medigene Ltd Immunomodulating heterocyclic compounds
GB0325644D0 (en) 2003-11-04 2003-12-10 Avidex Ltd Immuno ihibitory pyrazolone compounds
EP1692111A2 (en) 2003-12-12 2006-08-23 Wyeth, A Corporation of the State of Delaware Quinolines useful in treating cardiovascular disease
FR2870239B1 (fr) * 2004-05-11 2006-06-16 Sanofi Synthelabo Derives de carbamate de 2h- ou 3h-benzo[e]indazol-1-yle, leur preparation et leur application en therapeutique.
GB0411770D0 (en) * 2004-05-26 2004-06-30 Avidex Ltd Immuno inhibitory heterocyclic compouds
WO2006016093A1 (en) 2004-08-09 2006-02-16 Avidex Limited Immunomodulating oxopyrrazolocinnolines as cd80 inhibitors
ES2375877T3 (es) 2006-10-31 2012-03-07 Pfizer Products Inc. Compuestos de pirazolina como antagonistas de receptores de mineralocorticoides.
CN102372710A (zh) * 2010-08-18 2012-03-14 山东轩竹医药科技有限公司 作为盐皮质激素受体拮抗剂的并环类化合物
JPWO2012108511A1 (ja) 2011-02-09 2014-07-03 日産化学工業株式会社 ピラゾール誘導体および有害生物防除剤
CA3111878A1 (en) * 2018-09-07 2020-03-12 Merck Patent Gmbh 5-morpholin-4-yl-pyrazolo[4,3-b]pyridine derivatives
US11691971B2 (en) 2020-06-19 2023-07-04 Incyte Corporation Naphthyridinone compounds as JAK2 V617F inhibitors
WO2021257863A1 (en) 2020-06-19 2021-12-23 Incyte Corporation Pyrrolotriazine compounds as jak2 v617f inhibitors
TW202216713A (zh) 2020-07-02 2022-05-01 美商英塞特公司 作為jak2 v617f抑制劑之三環脲化合物
WO2022006456A1 (en) 2020-07-02 2022-01-06 Incyte Corporation Tricyclic pyridone compounds as jak2 v617f inhibitors
WO2022046989A1 (en) 2020-08-27 2022-03-03 Incyte Corporation Tricyclic urea compounds as jak2 v617f inhibitors
US11919908B2 (en) 2020-12-21 2024-03-05 Incyte Corporation Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors
WO2022182839A1 (en) 2021-02-25 2022-09-01 Incyte Corporation Spirocyclic lactams as jak2 v617f inhibitors
JP2025509672A (ja) 2022-03-17 2025-04-11 インサイト・コーポレイション Jak2 v617f阻害剤としての三環式尿素化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524146A (en) * 1982-12-08 1985-06-18 Ciba-Geigy Corporation Certain -2-heterocycle substituted pyrazoloquinolines
JPS61112075A (ja) * 1984-11-05 1986-05-30 Shionogi & Co Ltd チエニルピラゾロキノリン誘導体
SE8903564D0 (sv) * 1989-10-26 1989-10-26 Pharmacia Ab New use condensed quinoline compound
JPH05194515A (ja) * 1991-07-31 1993-08-03 Kyowa Hakko Kogyo Co Ltd 縮合ナフチリジン誘導体

Also Published As

Publication number Publication date
JP2000506884A (ja) 2000-06-06
AU2186797A (en) 1997-10-10
AU712141B2 (en) 1999-10-28
EP0888347A1 (en) 1999-01-07
EE9800298A (et) 1999-02-15
NO984290L (no) 1998-10-27
SK118798A3 (en) 1999-03-12
TR199801861T2 (xx) 1998-12-21
BR9708103A (pt) 1999-07-27
IL126271A0 (en) 1999-05-09
WO1997034893A1 (en) 1997-09-25
CN1218472A (zh) 1999-06-02
NZ331614A (en) 2000-07-28
NO984290D0 (no) 1998-09-16
KR20000064716A (ko) 2000-11-06
PL328921A1 (en) 1999-03-01
AR006520A1 (es) 1999-09-08
IS4848A (is) 1998-09-16
CZ297798A3 (cs) 1999-03-17
CA2247814A1 (en) 1997-09-25

Similar Documents

Publication Publication Date Title
ID16283A (id) Senyawa yang berguna dibidang farmasi
ID15858A (id) Turunan triazol yang berguna dalam terapi
FI970762L (fi) Terapiassa käyttökelpoiset spiroatsabisykliset yhdisteet
DE69623616D1 (de) Bandscheibenstabilisator
ID17689A (id) Silika yang diendapkan dalam bentuk amorf
IT1282692B1 (it) Citochine modificate per l'uso in terapia
NO951345D0 (no) Stolpesko
ID19871A (id) Turunan-turunan kuinoksalin yang berguna dalam terapi
KR970056943U (ko) 약제 분쇄기
KR950029322U (ko) 안락 의지대
KR960006934U (ko) 의자
KR970050997U (ko) 의료용자석
KR960006928U (ko) 위치변형 가능한 의자
KR960009822U (ko) 의자
KR970053336U (ko) 의자
BR7401857U (pt) Disposição introduzida em cadeira
BR7401899U (pt) Cadeira de praia
BR7401550U (pt) Cadeira de praia
FI1691U1 (fi) Hopsaettningsmaskin foer lastpallsben
FI2504U1 (fi) Tuoli
SE9604136D0 (sv) Stol
SE9701730D0 (sv) Stol
BR7600765U (pt) Disposição introduzida em assento ortopédico
BR7600120U (pt) Disposiçao introduzida em colchao
KR960019872U (ko) 휴대용 의자